Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

about

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

Item

http://www.wikidata.org/entity/Q52604402

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

@en

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

@nl

type

Item

label

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

@en

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

@nl

prefLabel

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

@en

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

@nl

P1476

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

@en

P2093

Chunzhang Yang

http://www.w3.org/2001/XMLSchema#string

Yang Liu

http://www.w3.org/2001/XMLSchema#string

Yanxin Lu

http://www.w3.org/2001/XMLSchema#string

Ying Pang

http://www.w3.org/2001/XMLSchema#string

P2860

XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage

Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro

DNA repair targeted therapy: The past or future of cancer treatment?

Profile of veliparib and its potential in the treatment of solid tumors

Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken

Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

P31

scholarly article

P356

10.1016/J.PHARMTHERA.2018.03.006

http://www.w3.org/2001/XMLSchema#string

P50

Karel Pacak

P577

2018-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29621593

http://www.w3.org/2001/XMLSchema#string

P932

6067963

http://www.w3.org/2001/XMLSchema#string